Literature DB >> 8867868

Risk factors for orofacial and limbtruncal tardive dyskinesia in older patients: a prospective longitudinal study.

J S Paulsen1, M P Caligiuri, B Palmer, L A McAdams, D V Jeste.   

Abstract

Although there is a consensus that orofacial and limbtruncal subtypes of tardive dyskinesia (TD) exist and may represent distinct pathophysiologic entities, few studies have examined the incidence of and risk factors associated with the development of these TD subtypes. Two hundred and sixty-six middle-aged and elderly outpatients with a median duration of 21 days of total lifetime neuroleptic exposure at study entry were evaluated at 1- to 3-month intervals. Using "mild" dyskinesia in any part of the body for diagnosis of TD, the cumulative incidence of orofacial TD was 38.5 and 65.7% after 1 and 2 years, respectively, whereas that of limbtruncal TD was 18.6 and 32.6% after 1 and 2 years. Preclinical dyskinesia was predictive of both orofacial and limbtruncal TD. History of alcohol abuse or dependence was a significant predictor of orofacial TD only whereas tremor was a significant predictor of limbtruncal TD only. Findings support suggestions that orofacial and limbtruncal TD may represent specific subsyndromes with different risk factors.

Entities:  

Mesh:

Year:  1996        PMID: 8867868     DOI: 10.1007/bf02246639

Source DB:  PubMed          Journal:  Psychopharmacology (Berl)        ISSN: 0033-3158            Impact factor:   4.530


  51 in total

1.  The association among negative symptoms, movement disorders, and frontal lobe psychological deficits in schizophrenic patients.

Authors:  K W Brown; T White
Journal:  Biol Psychiatry       Date:  1991-12-15       Impact factor: 13.382

2.  Orofacial dyskinesia and the alcohol dependence syndrome.

Authors:  J V Lucey; T G Dinan
Journal:  Psychol Med       Date:  1992-02       Impact factor: 7.723

3.  Levodopa-induced dyskinesias in parkinsonian monkeys: relationship to extent of nigrostriatal damage.

Authors:  J S Schneider
Journal:  Pharmacol Biochem Behav       Date:  1989-09       Impact factor: 3.533

4.  Development of a rating scale for primary depressive illness.

Authors:  M Hamilton
Journal:  Br J Soc Clin Psychol       Date:  1967-12

5.  Prospective study of tardive dyskinesia incidence in the elderly.

Authors:  B L Saltz; M G Woerner; J M Kane; J A Lieberman; J M Alvir; K J Bergmann; K Blank; J Koblenzer; K Kahaner
Journal:  JAMA       Date:  1991-11-06       Impact factor: 56.272

Review 6.  Tardive dyskinesia: prevalence and risk factors, 1959 to 1979.

Authors:  J M Kane; J M Smith
Journal:  Arch Gen Psychiatry       Date:  1982-04

7.  Effect of cholinergic and anticholinergic agents on tardive dyskinesia.

Authors:  H L Klawans; R Rubovits
Journal:  J Neurol Neurosurg Psychiatry       Date:  1974-08       Impact factor: 10.154

8.  Loss of neurons in the nucleus basalis of Meynert in Alzheimer's disease, paralysis agitans and Korsakoff's Disease.

Authors:  T Arendt; V Bigl; A Arendt; A Tennstedt
Journal:  Acta Neuropathol       Date:  1983       Impact factor: 17.088

9.  Risk of tardive dyskinesia in older patients. A prospective longitudinal study of 266 outpatients.

Authors:  D V Jeste; M P Caligiuri; J S Paulsen; R K Heaton; J P Lacro; M J Harris; A Bailey; R L Fell; L A McAdams
Journal:  Arch Gen Psychiatry       Date:  1995-09

10.  An unusual cluster of tardive dyskinesia in schizophrenia: association with cognitive dysfunction and negative symptoms.

Authors:  J L Waddington; H A Youssef
Journal:  Am J Psychiatry       Date:  1986-09       Impact factor: 18.112

View more
  1 in total

1.  [Antipsychotic-induced motor symptoms in schizophrenic psychoses-Part 3 : Tardive dyskinesia].

Authors:  D Hirjak; K M Kubera; S Bienentreu; P A Thomann; R C Wolf
Journal:  Nervenarzt       Date:  2019-05       Impact factor: 1.214

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.